Elena Pope

Title: Division Head, Division of Paediatric Dermatology, Department of Paediatrics

Designations: MD, M.Sc., FRCPC

Fax: 416-813-7909

Alternate Contact Name: Jessica Rosales

Alternate Email: jessica.rosales@sickkids.ca

U of T Positions: Professor, Department of Paediatrics

Research Positions

Project Investigator, SickKids Research Institute

Chair positions

2017–Present: Chair, Pediatric Dermatology Research Alliance (PeDRA)
2019–2022: Chair, Strategic Committee, Society for Pediatric Dermatology
2019–2021: Course Director, Society for Paediatric Dermatology Annual Meeting, Toronto 2021

Biography

Dr. Elena Pope is an academic paediatrician with over 20 years of special expertise in paediatric skin disorders, involved in all aspects of clinical, education and research pertaining to the specialty. She has a special interest in rare, orphan diseases that require team collaboration and innovative clinical and research approaches. Dr. Pope created/co-created and has led specialized clinics in rare vascular tumors, epidermolysis bullosa, genodermatoses, morphea and cutaneous lymphoma. She is involved in teaching at all levels and research that stems from her clinical interests.

Education and experience

2021–2022: Diploma in Magic Wand Clinical Innovation Program, Harvard University, Cambridge Massachusetts, USA.
2009–2012: Postgraduate Diploma, Clinical Trials Program, London School of Hygiene and Tropical Medicine, United Kingdom
2000–2001: Fellowship in Paediatric Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada
1999: FRCPC Paediatric Fellowship, Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada
1995–1996: MD, Ontario International Medical Graduate Program, University of Toronto, Toronto, Ontario, Canada
1994–1995: M.Sc., Pharmacology, University of Toronto, Toronto, Ontario, Canada
1984–1990: MD, Faculty of Pediatrics, The Institute of Medicine and Pharmacology, Bucharest, Romania

Achievements

2021–Present: ISPD Board Member and Chair of the Scientific Committee
2019: Honorary Member, Canadian Dermatology Association

Publications

Liy-Wong, C., Pope, E., Weinstein M, Lara-Corrales, I. Staphylococcal Scalded Skin Syndrome: An epidemiological and clinical review of 84 cases. 2021 January. 38(1):149-153. doi:10.1111/pde.14470. Epub 2020 December 1. PMID: 33283348 Pediatric Dermatology COLL
Liy-Wong, C., Tarango, C., Pope, E., Coates, T., Bruckner, A. L., Feinstein, J. A., Schwieger-Briel, A., Hubbard, L. D., Jane, C., Torres-Pradilla, M., Zmazek, M., & Lara-Corrales, I. (2023). Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet journal of rare diseases, 18(1), 38.
Abdalla, M., Chen, B., Santiago, R., Young, J., Eder, L., Chan, A., Pope, E., Tu, K., Jaakkimainen, L., Drucker, A. Accuracy of algorithms to identify people with atopic dermatitis in Ontario routinely collected health databases. 2021 Journal of Investigative Dermatology. (JID-2020-0792.R3). 2021 February. S0022-202X (21)00083-X. doi: 10.1016/j.jid.2021.01.009. PMID: 33571528 COLL
Pope, E., Li S. Higgins G., Chen M., Torok K., Rabinovitch CE, Stewart K., Laxer R., Haines K., Punaro M., O’ Neil KM. Extracutaneous Involvement is Common and Associated with Prolonged Disease Activity and Greater Impact in Juvenile Localized Scleroderma. Rheumatology. 2021 March. doi: 10.1093/rheumatology/keab238. PMID: 33711155 COLL
Lansang, P., Bergman, J. N., Fiorillo, L., Joseph, M., Lara-Corrales, I., Marcoux, D., McCuaig, C., Pope, E., Prajapati, V. H., Li, S. Z. J., & Landells, I. (2020). Management of pediatric plaque psoriasis using biologics. Journal of the American Academy of Dermatology, 82(1), 213–221.

See a full list of Elena Pope's publications

2020–2021: Co-A. Consensus- based recommendations for management of pediatric mycosis fungoides: The ARMFUL (AppRoach Mycosis Fungoides in children) study. Zvuolunov A, Pope E. PeDRA Consensus Grant. ($15,000 USD)
2020–2022: Co-A. Skin Investigation Network of Canada (SkIN Canada). Chan A, Dutz J, Phillip A, Andrews-Clay K, Drucker A, Fradette M, Germain L, Litvinov I, Piguet V, Zhou Y, Grimshaw J. Hedtrich S, Mydlarski R, Biernaskie J, Cross K, Ghahary A, Hedtrich S, Hinz B, Leask A, Moulin V, Reinhardt D, Roy S, Gniadecki R, Mydlarski R, Alhusayen R, Bissonnette R, Papp K, Pope E, Rosen C, Alavi A, Logsetty S, Kalia S, Lui H, Knoppers B, Zawati, M. CIHR – Network Catalyst Grant ($1, 200,000 CAD)
2019–2022: Site-PI. A phase 2 randomized, multicenter, double-blind, vehicle-controlled, 12-week safety, efficacy and systemic exposure study followed by a 12-week open-label extension of Trifarotene (CD5789) cream in adult and children with lamellar ichthyosis. Pope E. Mayne Pharma LLC. ($64,610 CAD)
2019–2020: PI. Epidermolysis Bullosa Clinical Characterization and Outcomes Database. Pope E, Lara-Corrales I. EB Medical Research Foundation. ($12,767 CAD)
2019–2022: PI. The Efficacy and Safety of AVC-516942 (3% Cannabidiol) Cream in patients with Epidermolysis Bullosa: A Phase II/II trial. Pope E, Lara-Corrales I. Avicanna Canada. ($238,195 CAD)

2020–2021: Co-A. Consensus- based recommendations for management of pediatric mycosis fungoides: The ARMFUL (AppRoach Mycosis Fungoides in children) study. Zvuolunov A, Pope E. PeDRA Consensus Grant. ($15,000 USD)

2020–2022: Co-A. Skin Investigation Network of Canada (SkIN Canada). Chan A, Dutz J, Phillip A, Andrews-Clay K, Drucker A, Fradette M, Germain L, Litvinov I, Piguet V, Zhou Y, Grimshaw J. Hedtrich S, Mydlarski R, Biernaskie J, Cross K, Ghahary A, Hedtrich S, Hinz B, Leask A, Moulin V, Reinhardt D, Roy S, Gniadecki R, Mydlarski R, Alhusayen R, Bissonnette R, Papp K, Pope E, Rosen C, Alavi A, Logsetty S, Kalia S, Lui H, Knoppers B, Zawati, M. CIHR – Network Catalyst Grant ($1, 200,000 CAD)

2019–2022: Site-PI. A phase 2 randomized, multicenter, double-blind, vehicle-controlled, 12-week safety, efficacy and systemic exposure study followed by a 12-week open-label extension of Trifarotene (CD5789) cream in adult and children with lamellar ichthyosis. Pope E. Mayne Pharma LLC. ($64,610 CAD)

2019–2020: PI. Epidermolysis Bullosa Clinical Characterization and Outcomes Database. Pope E, Lara-Corrales I. EB Medical Research Foundation. ($12,767 CAD)

2019–2022: PI. The Efficacy and Safety of AVC-516942 (3% Cannabidiol) Cream in patients with Epidermolysis Bullosa: A Phase II/II trial. Pope E, Lara-Corrales I. Avicanna Canada. ($238,195 CAD)

Section of Dermatology

Our busy Dermatology Department sees over 8,000 visits per year spread across two running clinics.

AboutKidsHealth

Dermatology Learning Hub

Information about common skin conditions such as eczema, diaper rash, sunburn, warts, head lice, hair loss, birthmarks and more. Also learn about first aid and everyday care so your child can have healthy hair, skin and nails.